Non-Peptidic Inhibitors of Cysteine Proteases

被引:35
|
作者
Schirmeister, T. [1 ]
Kaeppler, U. [1 ]
机构
[1] Univ Wurzburg, Dept Pharmaceut Chem, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany
关键词
D O I
10.2174/1389557033488079
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In comparison to the huge number of peptidic and peptidomimetic inhibitors of cysteine proteases which have been developed during the last twenty years the number of non-peptidic compounds with cysteine protease inhibiting properties is restricted to a few substance classes. In contrast to peptidic and peptidomimetic inhibitors the non-peptidic lead structures have mainly been discovered by computational or enzymatic industrial screenings and not by a rational approach. But, the growing number of resolved X-ray structures of the target enzymes as well as molecular modeling methods have supported the further development of potent inhibitors beginning from these lead structures. In this review we will focus on new non-peptidic cysteine protease inhibitors which have been developed during the last years. Discovery, structure-activity-relationship and inhibition mechanisms will be discussed.
引用
收藏
页码:361 / 373
页数:13
相关论文
共 50 条
  • [31] New non-peptidic Inhibitors of Papain Derived from Etacrynic Acid
    Kaeppler, U.
    Schirmeister, T.
    MEDICINAL CHEMISTRY, 2005, 1 (04) : 361 - 370
  • [32] Discovering non-peptidic inhibitors for matrix metalloproteinases with their recombinant catalytic domains
    Ye, QZ
    Johnson, L
    Hupe, D
    FASEB JOURNAL, 1997, 11 (09): : A1399 - A1399
  • [33] Potent small molecule, non-peptidic chlorophenyl acetamide thrombin inhibitors
    Lee, L
    Kreutter, KD
    Pan, WX
    Lu, TB
    Crysler, C
    Eisennagel, S
    MacMillan, M
    Spurlino, J
    Tomczuk, B
    Player, M
    Mohan, V
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U152 - U152
  • [34] Discovery of novel non-peptidic ketopiperazine-based renin inhibitors
    Holsworth, DD
    Powell, NA
    Downing, DM
    Cai, C
    Cody, WL
    Ryan, JM
    Ostroski, R
    Jalaie, M
    Bryant, JW
    Edmunds, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (07) : 2657 - 2664
  • [35] The discovery and optimization of potent non-peptidic matrix metalloprotease inhibitors.
    Benz, GHH
    Blake, P
    Brittelli, DR
    Bullock, WH
    Combs, KJ
    Dally, R
    Dixon, BR
    Ha, S
    Heald, S
    Housley, T
    Janis, R
    Katti, S
    Kluender, HC
    Maniglia, C
    Niedbala, M
    Perry, C
    Phelan, K
    Robbins, A
    Schneider, S
    Schoenleber, R
    Scott, W
    Tilton, R
    VanZandt, M
    Wilhelm, S
    Wolanin, D
    Wood, JE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 111 - MEDI
  • [36] Non-Peptidic α-Helical Mimetics as Protein-Protein Interaction Inhibitors
    Dewal, M. B.
    Firestine, S. M.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (16) : 2420 - 2428
  • [37] Towards the prediction of non-peptidic epitopes
    Zierep, Paul F.
    Vita, Randi
    Blazeska, Nina
    Moumbock, Aurelien F. A.
    Greenbaum, Jason A.
    Peters, Bjoern
    Guenther, Stefan
    PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (02)
  • [38] Non-peptidic GnRH receptor antagonists
    Armer, RE
    Smelt, KH
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (22) : 3017 - 3028
  • [39] SPECULATIONS ON THE DESIGN OF NON-PEPTIDIC PEPTIDOMIMETICS
    FARMER, PS
    ARIENS, EJ
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (09) : 362 - 365
  • [40] Discovery of small non-peptidic CD4 inhibitors as novel immunotherapeutics
    Li, S
    Gao, JM
    Satoh, T
    Friedman, TM
    Edling, AE
    Koch, U
    Choksi, S
    Han, XB
    Korngold, R
    Huang, ZW
    PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 517 - 519